29 +/- 4.97 vs. 7.06 +/- 2.17 ng mu L(-1) in the low BMD group (P = 0.012). C-telopeptide levels in the normal group were 1.06 +/- 1.4 vs. 0.74 +/- 0.3 ng mL(-1) in the low BMD group (P = 0.169). Our results showed that low osteocalcin levels predominated in the group with low BMD, which indicates a diminished osteoblastic bone formation activity while there
were no differences with regard to bone resorption markers. Moreover, osteocalcin levels explain 10% of the variation of lumbar spine Z-score.”
“Objective: To study patients’ satisfaction in rehabilitation services and its relation NCT-501 manufacturer to staff job satisfaction in public, private and teaching hospitals in Jeddah. Method: A cross sectional survey was used to measure patients’ satisfaction with rehabilitation services in ten different hospitals in Jeddah (Kingdom of Saudi Arabia). A validated Monnin and Perneger’s questionnaire with a 5-points Likert scale was utilized. At the same time, staff job satisfaction was measured by the Effort-Reward Imbalance model in the same health care facilities. Results: On 725 patients
who responded to the survey, 80.6% were overall satisfied with the rehabilitation services they received. Patient satisfaction was significantly different (p=0.001) between hospital types. In average, 88.5% of the patients of Selleck HM781-36B the teaching hospitals were satisfied with the rehabilitation services, compared
to selleck kinase inhibitor 77% of the patients in the public hospitals and 75.7% of the patients in the private hospitals. Moreover there was no statistically significant correlation between staff job satisfaction and patients’ satisfaction. Conclusion: Patients’ satisfaction with rehabilitation services was the highest in the teaching hospitals in comparison with the other types of health care facilities. Patients’ satisfaction was however not significantly correlated with the staff job satisfaction. [Isabelle CN Devreux, Agnes Jacquerye, France Kittel, Enas Elsayed and Bahjat Al-Awa Benchmarking of patient satisfaction with physical rehabilitation services in various hospitals of Jeddah] Life Science Journal 2012; 9(3):73-78]. (ISSN: 1097-8135). http://www.lifesciencesite.com. 11″
“delta opioid peptide (DOP) receptors are considered a therapeutic target in Parkinson’s disease, although the use of DOP agonists may be limited by side effects, including convulsions. To circumvent this issue, we evaluated whether blockade of nociceptin/orphanin FQ (N/OFQ) tone potentiated the antiparkinsonian effects of DOP agonists, thus allowing for reduction of their dosage.